News · 26 weeks22-75%
2025-10-262026-04-19
Mix1190d
- SEC Filings7(64%)
- Earnings2(18%)
- Insider1(9%)
- Other1(9%)
Latest news
25 items- SECSEC Form DEF 14A filed by InfuSystems Holdings Inc.DEF 14A - InfuSystem Holdings, Inc (0001337013) (Filer)
- SECInfuSystems Holdings Inc. filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits8-K - InfuSystem Holdings, Inc (0001337013) (Filer)
- SECInfuSystems Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - InfuSystem Holdings, Inc (0001337013) (Filer)
- PRInfuSystem to Participate at 38th Annual ROTH Conference on March 23, 2026InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"),a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today that Carrie Lachance, President and Chief Executive Officer and Barry Steele, Chief Financial Officer, will participate in the 38th Annual ROTH Conference on Monday, March 23, 2026. The conference will be held at The Ritz-Carlton Laguna Niguel in Dana Point, California. Management is scheduled to host in-person one-on-one meetings held throughout the day. Investors interested in arranging one-on-one meetings with InfuSystem should contact their ROTH Capital
- INSIDERExecutive VP and CFO Steele Barry G bought $18,906 worth of shares (2,064 units at $9.16), increasing direct ownership by 2% to 88,000 units (SEC Form 4)4 - InfuSystem Holdings, Inc (0001337013) (Issuer)
- SECInfuSystems Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - InfuSystem Holdings, Inc (0001337013) (Filer)
- SECSEC Form 10-K filed by InfuSystems Holdings Inc.10-K - InfuSystem Holdings, Inc (0001337013) (Filer)
- SECInfuSystems Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - InfuSystem Holdings, Inc (0001337013) (Filer)
- PRInfuSystem Announces Financial Results for Fourth Quarter and Full Year 2025Full Year 2025 vs. Full Year 2024: Seventh Consecutive Year of Record Net Revenues: $143.4 million, Up 6% Net Income Increased to: $6.6 million, Up 183% Record Adjusted EBITDA (non-GAAP): $31.5 million, Up 24% Record Operating Cash Flow of $24.4 million, Up 19%: InfuSystem Holdings, Inc. (NYSE:INFU), ("InfuSystem" or the "Company"), a leading national healthcare service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today reported financial results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter Overview: Net revenues totaled $36.2 million, an increase of 7% vs. prior year. Patient Services
- SECInfuSystems Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - InfuSystem Holdings, Inc (0001337013) (Filer)
- PRInfuSystem to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026Investor Conference Call to be held 9:00 a.m. Eastern Time InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today it will issue preliminary fourth quarter and full year 2025 financial results on Tuesday, February 24, 2026, before the market opens. The Company will also conduct a conference call for all interested parties on Tuesday, February 24, 2026 at 9:00 a.m. Eastern Time to discuss its financial results. To participate in this call, please dial (833) 366-1127 or (412) 902-6773, or listen via a live web
- PRAmbulatory Infusion Pumps used in Pain Management Business by InfuSystem to Receive Separate Payment Under NOPAIN Act Starting January 1, 2026InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today that the Centers for Medicare and Medicaid Services ("CMS") has added two of the electronic infusion pumps currently utilized by the Company within its Pain Management services business to the list of qualifying products for separate payment in conjunction with the Non-Opioids Prevent Addiction in the Nation ("NOPAIN") Act. The NOPAIN Act mandates that CMS provide separate payment for qualified non-opioid treatments through December 31, 2027 when provided wit
- SECInfuSystems Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - InfuSystem Holdings, Inc (0001337013) (Filer)
- SECSEC Form SCHEDULE 13G filed by InfuSystems Holdings Inc.SCHEDULE 13G - InfuSystem Holdings, Inc (0001337013) (Subject)
- SECInfuSystems Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - InfuSystem Holdings, Inc (0001337013) (Filer)
- SECInfuSystems Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - InfuSystem Holdings, Inc (0001337013) (Filer)
- PRInfuSystem to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18, 2025InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"),a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today Carrie Lachance, President and Chief Executive Officer and Barry Steele, Chief Financial Officer, will participate in the 16th Annual Craig-Hallum Alpha Select Conference on Tuesday, November 18, 2025. The conference will be held at the Sheraton New York Times Square Hotel in New York City. Management is scheduled to host in-person one-on-one meetings held throughout the day. Investors interested in arranging one-on-one meetings should contact your Craig-Hal
- SECSEC Form 10-Q filed by InfuSystems Holdings Inc.10-Q - InfuSystem Holdings, Inc (0001337013) (Filer)
- PRInfuSystem Reports Third Quarter 2025 Financial ResultsRecord Net Revenues of $36.5 million Representing 3% Growth from the Prior Year Net income of $2.3 million, up 25% Adjusted EBITDA (non-GAAP) of $8.3 million, up 6% Adjusted EBITDA (non-GAAP) margin expanded by 0.5% to 23% Year-to-Date Net Operating Cash Flow of $17.3 million, up 38% Stock Repurchases totaled $2.2 million during third quarter Reaffirms Full-Year 2025 Guidance InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, today reported financial results for the third quarter ended September 30, 2025. 2025 Third Quarte
- SECInfuSystems Holdings Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - InfuSystem Holdings, Inc (0001337013) (Filer)
- PRInfuSystem to Report Third Quarter 2025 Financial Results on November 4, 2025Investor Conference Call to be held 9:00 a.m. Eastern Time InfuSystem Holdings, Inc. (NYSE:INFU) ("InfuSystem" or the "Company"), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today it will issue third quarter 2025 financial results on Tuesday, November 4, 2025, before the market opens. The Company will also conduct a conference call for all interested parties on Tuesday, November 4, 2025 at 9:00 a.m. Eastern Time to discuss its financial results. To participate in this call, please dial (833) 366-1127 or (412) 902-6773, or listen via a live webcast, which is available in t
- SECInfuSystems Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - InfuSystem Holdings, Inc (0001337013) (Filer)
- INSIDEREVP-Chief HR Officer Funke Jerod converted options into 12,500 shares and covered exercise/tax liability with 3,669 shares, increasing direct ownership by 90% to 18,662 units (SEC Form 4)4 - InfuSystem Holdings, Inc (0001337013) (Issuer)
- SECInfuSystems Holdings Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - InfuSystem Holdings, Inc (0001337013) (Filer)
- PRInfuSystem to Present at 4th Annual ROTH Healthcare Opportunities Conference on October 9, 2025InfuSystem Holdings, Inc. (NYSE: INFU) ("InfuSystem" or the "Company"),a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today Carrie Lachance, CEO and Barry Steele, Chief Financial Officer, will participate at the 4th Annual ROTH Healthcare Opportunities Conference on Thursday, October 9, 2025. The conference will be held at the Metropolitan Club in New York City. Management is scheduled to host virtual one-on-one meetings throughout the day. Investors interested in arranging one-on-one meetings should contact your conference representative. Conversely, you may also call or email